The short version of reference standard fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-19 and is reviewed periodically as new material appears.
Lyophilized peptide material is typically stored at or below -20 °C, with -80 °C used for longer-term archives. Vials should remain sealed and desiccated because moisture promotes aggregation and hydrolysis. Repeated freeze-thaw cycles are avoided since they can alter peptide conformation and reduce recovery. Once reconstituted, solutions are generally kept at 2-8 °C and used within a defined window. Stability beyond those windows depends on buffer composition and concentration, and exact limits are product-specific rather than universal.
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities by hydrophobicity. Mass spectrometry confirms molecular weight and detects truncation or modification products. Peptide mapping after enzymatic digestion verifies the amino acid sequence. Quantitation is often performed by LC-MS/MS or by immunoassay, and the two approaches can give different values because they measure different things. Method validation parameters such as accuracy, precision, and limit of quantitation are reported alongside results.
Certificate of analysis documents from suppliers typically report purity by chromatographic area, water content, and counter-ion identity. Independent verification is advisable because reported values can be generated under differing conditions. Impurity profiles matter for research use, where aggregates, deamidation products, and residual solvents may influence experimental results. Container, lot, and chain-of-custody records support traceability. Analytical results are method-dependent, so comparisons between laboratories require the same procedure and reference standards.
Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.
Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.
| Property | Value | Notes |
|---|---|---|
| Storage temperature | -20 °C or below | Lyophilized powder; -80 °C for long-term archival |
| Post-reconstitution storage | 2-8 °C | Refrigerated; avoid repeated freeze-thaw |
| Routine purity method | Reversed-phase HPLC | Separates peptide from related impurities |
| Identity confirmation | Mass spectrometry | Confirms molecular mass and detects truncation |
| Water solubility | Freely soluble | Depends on salt form and buffer composition |
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Routine characterisation of the peptide relies on reversed-phase high-performance liquid chromatography, often paired with ultraviolet detection near 214 nanometres. Related substances such as deamidated, oxidised, and truncated sequences elute at characteristic positions and are quantified by area percentage. Electrospray ionisation mass spectrometry confirms the molecular mass and can resolve some closely related variants. Peptide mapping after enzymatic digestion provides sequence-level verification and is useful when a full identity profile is required. Method parameters such as column chemistry, gradient, and mobile-phase pH influence the separation and must be reported alongside results.
Material described as research-grade is not necessarily manufactured to pharmaceutical standards, and purity figures depend on the method used to obtain them. A certificate of analysis states the measured purity, the analytical technique, and the batch identifier, but the underlying data are not always included. Independent testing by a second laboratory is a common way to confirm identity and purity. Uncertainties remain about how storage history affects long-term stability, and about how well results from one laboratory transfer to another. Documentation of handling conditions supports comparison between batches.
Microsoft's acquisition of Bethesda Softworks in 2021 was seen as providing several potential killer app games for the Xbox Series X/S, notably Starfield from Bethesda Game Studios, which in addition to launching as a console exclusive in 2023, became a significantly focused game in Xbox's advertising of the consoles in addition to replacing prior tentpole exclusive Halo Infinite (2021) as the key visual game featured on the packaging of Xbox Series X. Ratchet & Clank: Rift Apart was seen as a killer app for the PlayStation 5 due to being a game released at a point in the console's lifecycle where much of the first-party software from Sony was also supplemented by a simultaneous release on PlayStation 4, in addition to being highlighted for its graphical fidelity and use of the console's various hardware features such as faster loading and the functions of the DualSense controller. Mario Kart World and Donkey Kong Bananza are seen as and were positioned by Nintendo as killer apps for the launch window of Nintendo Switch 2, both for their technical improvements over previous entries in their respective series, and for gameplay innovations such as World's open "Free Roam" mode and Bananza's destructible sandbox environments that leverage the increase in hardware potency. Pokémon games are killer apps for Nintendo handhelds, often topping the best-selling charts for whatever system they appear on.
Biopharmaceuticals may be produced from microbial cells (e.g., recombinant E. coli or yeast cultures), mammalian cell lines (see Cell culture) and plant cell cultures (see Plant tissue culture) and moss plants in bioreactors of various configurations, including photo-bioreactors. Important issues of concern are cost of production (low-volume, high-purity products are desirable) and microbial contamination (by bacteria, viruses, mycoplasma). Alternative platforms of production which are being tested include whole plants (plant-made pharmaceuticals).
(2026) describe a late Pliocene proboscidean and even-toed ungulate assemblage (the Dongyancun Fauna) from the Sanmenxia Basin (Zhongtiao Mountains; China), including the first reported Pliocene record of Leptobos in northern China, and providing evidence of composition of large herbivore assemblages in northern China shortly before Quaternary climate changes, arrival of true horses and appearance of Mammuthus meridionalis. Shidqi et al. (2026) review the fossil record of Pleistocene mammals from Sumatra (Indonesia), reporting evidence of presence of mammals with Indochinese and Sundaic affinities and evidence of limited taxonomic losses since the late Middle Pleistocene. Zhang et al. (2026) report the discovery of new fossil material of Early Pleistocene mammals from the Yeka locality in the Shangri-La region (Yunnan, China), and interpret the composition of the studied assemblage as indicative of an environment including a forest mixed with a grassland landscape. Linchamps et al. (2026) study the composition of the Early Pleistocene small mammal assemblage from the Gondolin GD2 locality (South Africa), interpreted as indicative of environments dominated by grassland and open savannas.
Sources: en.wikipedia.org
== Plays == Vera; or, The Nihilists (1880/1882) (text) The Duchess of Padua (1883) (text) Lady Windermere's Fan (1892) (text) A Woman of No Importance (1893) (text) An Ideal Husband (1895) (text) The Importance of Being Earnest (1895) (text) Salomé (1896) Translated from French by Lord Alfred Douglas (text) La Sainte Courtisane (Incomplete) (text) A Florentine Tragedy (Incomplete) (text) (Dates are dates of first performance, which approximate better to the probable date of composition than dates of publication.)
=== Halogenated pyridines === Monohalogenated of pyridines are colorless materials, the fluorides, chlorides, and bromides being liquids. The moniodopyridines are solids. 2-Chloropyridine, obtained by direct reaction of pyridine with chlorine, is of considerable commercial significance. The fluoropyridine and iodopyridines are prepared via the diazotization of the corresponding aminopyridines. A variety of di-, tri-, tetra-, and pentahalopyridines are known, including heterohalides such a fluoroiodopyridines.
==== Breast-filler toxicity ==== Biological risks to the health of a sucking infant arise from the possibility of breast-filler toxicity, that the filler-material (saline solution or silicone gel) might leak from the breast-implant into the body of the mother, then into her breast milk, and then into the infant organism; yet the biological risk to the breastfeeding infant is minimal, because silicone is indigestible and saline-solution is digestible. The study Silicone Breast Implants and Breastfeeding (1996) indicated that possible medical complications that impede breastfeeding can arise among women with silicone-filled prosthetic breasts, and found no causal relation between the presence of breast prostheses and neurological and physical impairment of the breastfeeding function of the augmented breasts.
Sources: en.wikipedia.org
=== BPI lawsuit === On September 13, 2012, BPI announced that it filed a $1.2 billion lawsuit, Beef Products, Inc. v. American Broadcasting Companies, Inc., against ABC News; three reporters (Diane Sawyer, Jim Avila and David Kerley) and others, claiming ABC News made nearly "200 false, misleading and defamatory statements, repeated continuously during a month-long disinformation campaign", engaged in "product and food disparagement, and tortious interference with business relationships". BPI called the ABC News series a "concerted disinformation campaign" against LFTB. ABC News denied BPI's claims, and called the lawsuit without merit. ABC News sought to have the case removed from South Dakota state court to federal court. In June 2013, a federal judge sent the lawsuit back to state court. On March 27, 2014, South Dakota state court Judge Cheryle Gering rejected ABC's motion to dismiss, and allowed the defamation suit to move forward. Diane Sawyer's motion for summary judgment was granted and she was dismissed. The trial of the case began June 5, 2017, in Elk Point, South Dakota. The trial, in a courthouse remodeled for the occasion, was expected to take 8 weeks, but was settled after three weeks. The court ruled that BPI is a public figure; thus, proof of "actual malice" is required to support a verdict of defamation. ABC was represented by Williams & Connolly, BPI by Winston & Strawn. South Dakota has a food disparagement law which may have permitted triple damages to $5.7 billion had there been a verdict for the plaintiff.
The energy released is about 180 kJ/mol, which is conserved when 2 ATP are generated from 2 ADP per glucose. Anaerobic bacteria and archaea use these and many other fermentative pathways, e.g., propionic acid fermentation, butyric acid fermentation, solvent fermentation, mixed acid fermentation, butanediol fermentation, Stickland fermentation, acetogenesis, or methanogenesis.
China is the world's largest producer and user of cement. In 2006, it was estimated that China manufactured 1.235 billion tonnes of cement, which was 44% of the world total cement production. "Demand for cement in China is expected to advance 5.4% annually and exceed 1 billion tonnes in 2008, driven by slowing but healthy growth in construction expenditures. Cement consumed in China will amount to 44% of global demand, and China will remain the world's largest national consumer of cement by a large margin." In 2010, 3.3 billion tonnes of cement was consumed globally. Of this, China accounted for 1.8 billion tonnes.
Sources: en.wikipedia.org
The lyophilized powder is dissolved in a suitable solvent, often sterile water or a buffered diluent, with gentle mixing rather than vigorous shaking. Foaming and shear should be avoided because they can promote aggregation. The resulting solution is then stored cold and protected from light.
It usually represents the proportion of total chromatographic area attributable to the main peak. That figure does not account for impurities that do not absorb at the detection wavelength or that co-elute with the main peak. It is a useful but incomplete indicator of overall quality.
Yes. Immunoassays and chromatographic methods recognize different molecular features and can yield divergent results. Even within one technique, differences in columns, gradients, and reference standards shift reported values. Comparable numbers require a shared procedure and a common standard.
It is a modified version of the natural hormone, with three amino acid changes and a fatty acid side chain added. These edits extend its half-life from minutes to about one week. The core receptor activity is retained.